Mazankowski Alberta Heart Institute
Edmonton, Alberta, T6G2B7, Canada
NCT Number: NCT01634438
At present, coronary angiogram is usually performed either through an artery in your groin or wrist. An important limitation of the wrist approach is an increase rate of blockage of the wrist artery. It is possible that the dose of blood thinner (i.e. heparin) may decrease the risk of blockage. Early studies seem to suggest that higher dose is required to reduce the risk of this important complication. However, to date there has not been a definitive study to determine the most appropriate heparin dose for the prevention of this complication. The main goal of this study is to determine the appropriate heparin dose to prevent wrist artery blockage and to determine risk factors for developing such a complication.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Edmonton, Alberta, T6G2B7, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
unfractionated heparin
Time frame: one month
The primary endpoint was radial artery occlusion defined as absence palpable radial artery with no flow as assessed by Doppler study
University of Alberta
Other
Low Versus High Dose Unfractionated Heparin in Patients Undergoing Angiography Via the Radial Artery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.